Non-Current Assets

Accumulated Depreciation

Amgen Accumulated Depreciation decreased by 16.2% to $9.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from $10.60B to $9.30B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows an upward trend with a 4.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026Apr 30, 2026
Parent metricPP&E (Net)

How to read this metric

A rising balance relative to gross assets suggests an aging infrastructure, potentially signaling a need for future capital expenditure to replace equipment.

Detailed definition

This is the cumulative amount of depreciation expense charged against the company's tangible assets since their acquisit...

Peer comparison

Commonly found in the balance sheet or notes for all companies with significant physical property, plant, and equipment.

Metric ID: ppe_accumulated_depreciation

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$9.10B$9.20B$8.80B$8.90B$9.00B$9.20B$9.30B$9.40B$9.50B$9.70B$9.80B$9.90B$10.10B$10.30B$10.40B$10.60B$10.80B$11.00B$11.10B$9.30B
QoQ Change+1.1%-4.3%+1.1%+1.1%+2.2%+1.1%+1.1%+1.1%+2.1%+1.0%+1.0%+2.0%+2.0%+1.0%+1.9%+1.9%+1.9%+0.9%-16.2%
YoY Change-1.1%+0.0%+5.7%+5.6%+5.6%+5.4%+5.4%+5.3%+6.3%+6.2%+6.1%+7.1%+6.9%+6.8%+6.7%-12.3%
% of PP&E (Net)185.5%184.7%169.8%173.1%174.5%177.3%171.4%172.2%171.7%174.4%165.0%164.9%165.7%167.3%158.9%158.7%157.5%152.4%140.3%113.2%
Share Change-0.8pp-14.9pp+3.3pp+1.4pp+2.8pp-6.0pp+0.8pp-0.4pp+2.6pp-9.4pp-0.0pp+0.7pp+1.7pp-8.4pp-0.3pp-1.1pp-5.2pp-12.1pp-27.1pp
Range$8.80B$11.10B
CAGR+0.5%
Avg YoY Growth+4.1%
Median YoY Growth+5.6%

Frequently Asked Questions

What is Amgen's accumulated depreciation?
Amgen (AMGN) reported accumulated depreciation of $9.30B in Q1 2026.
How has Amgen's accumulated depreciation changed year-over-year?
Amgen's accumulated depreciation decreased by 12.3% year-over-year, from $10.60B to $9.30B.
What is the long-term trend for Amgen's accumulated depreciation?
Over 5 years (2020 to 2025), Amgen's accumulated depreciation has grown at a 4.3% compound annual growth rate (CAGR), from $9.00B to $11.10B.
What does accumulated depreciation mean?
The total amount of depreciation recorded against physical assets over time.